News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioDelivery (BDSI) Provides Corporate Update And Reports Third Quarter 2016 Financial Results



11/10/2016 3:51:48 PM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Six BUNAVAIL® Managed Care Agreements Secured Since July; Additional Access to BUNAVAIL Provides Potential for Strong First Half 2017 Growth

Department of Health and Human Services Increases Patient Cap; Potential for Significant Increase in Patients Entering Treatment for Opioid Dependence

BDSI Meets Third Quarter Objective of Providing Stability to BUNAVAIL Prescription Sales Following Second Quarter Commercial Consolidation

BUNAVAIL Prescription Sales Up 68% Compared to Third Quarter 2015

Top-Line Phase 2b Data for Clonidine Topical Gel Expected in December

Buprenorphine 30-Day Injection IND Submission Expected by Year-End

Read at PR Newswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES